Absence of carcinogenicity of 1-nitropyrene, correction of previous results, and new demonstration of carcinogenicity of 1,6-dinitropyrene in rats.
HIROKO OHGAKI , HIROKAZU HASEGAWA , TAMAMI KATO , CHIE NEGISHI
Cancer Letters 25 ( 3) 239 -245
57
1985
Amplification and overexpression of MDM2 in primary (de novo) glioblastomas
WOJCIECH BIERNAT , PAUL KLEIHUES , YASUHIRO YONEKAWA , HIROKO OHGAKI
Journal of Neuropathology and Experimental Neurology 56 ( 2) 180 -185
154
1997
p53 mutations versus EGF receptor expression in giant cell glioblastomas.
AURELIA PERAUD , KUNIHIKO WATANABE , KARL H. PLATE , YASUHIRO YONEKAWA
Journal of Neuropathology and Experimental Neurology 56 ( 11) 1236 -1241
50
1997
TAKASHI SUGIMURA*, KEIJI WAKABAYASHI
MINAKO NAGAO , HIROKO OHGAKI
Diet, Nutrition, and Health 32 207 -207
1989
ABSENCE OF CARCINOGENICITY OF 1-NITROPYRENE
HIROKO OHGAKI , HIROKAZU HASEGAWA , TAMAMI KATO , CHIE NEGISHI
Collected Papers from the National Cancer Center Research Institute 21 ( 1) 12 -12
1985
Genetic alterations in granular cell astrocytomas
A Castellano-Sanchez , HH Ohgaki , Yokoo , SD Finkelstein
LABORATORY INVESTIGATION 82 ( 1) 298A -299A
2002
WHO classification of tumors—pathology and genetics of tumors of the nervous system
O Hiroko , DW Otmar
WHO 160 2007 -2007
13
2007
Derivation of a murine monoclonal antibody useful for immunohistochemical diagnosis of human adenoid cystic carcinoma and stomach cancer.
Hiroko Ohgaki , Nobuhiro Hayasaka , Teruyuki Hirota , Shigeaki Sato
Japanese Journal of Cancer Research 78 ( 9) 952 -959
1987
Expression of Fas/APO-1 during the Progression of Astrocytomas
Paul Kleihues , Hiroko Ohgaki , Kunihiko Watanabe , Hisayoshi Nakazawa
Cancer Research 55 ( 23) 5528 -5530
84
1995
Carcinogenicity in rats of a mutagenic compound, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, from tryptophan pyrolysate.
Yoko Nakatsuru , Hiroko Ohgaki , Shozo Takayama , Shigeaki Sato
Japanese Journal of Cancer Research 76 ( 9) 815 -817
25
1985
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Ivan Radovanovic , Hans-Georg Rammensee , Hiroko Ohgaki , Adriano Aguzzi
Cancer Research 62 ( 9) 2592 -2599
146
2002
Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
Catherine Gratas , Hiroko Ohgaki , Pierre Hainaut , Philippe Taniere
Cancer Research 58 ( 10) 2057 -2062
277
1998
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.
Avi Ashkenazi , Wolfgang Wick , Hiroko Ohgaki , Mathias Bähr
Cancer Research 61 ( 6) 2759 -2765
295
2001
Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds
Paul Kleihues , Hiroko Ohgaki , Gordon C. Hard , Michihito Takahashi
Cancer Research 52 ( 10) 2995 -2998
62
1992
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
David E. Goldgar , Paul Kleihues , Rosalind A. Eeles , Nayanta Sodha
Cancer Research 63 ( 20) 6643 -6650
611
2003
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
Andreas von Deimling , Paul Kleihues , Hiroko Ohgaki , Robert H. Eibl
Cancer Research 52 ( 10) 2987 -2990
269
1992
Genetic Control of Susceptibility of Rats to Gastric Carcinoma
Hiroko Ohgaki , Norio Matsukura , Takashi Kawachi , Kazuhide Morino
Cancer Research 43 ( 8) 3663 -3667
58
1983
Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation.
Peter M. Lansdorp , Hiroko Ohgaki , M. Prakash Hande , Luciane R. Cavalli
Cancer Research 62 ( 23) 6990 -6996
107
2002
Differential proliferative response of gastric mucosa during carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in susceptible ACI rats, resistant Buffalo rats, and their hybrid F1 cross.
Paul Kleihues , Hiroko Ohgaki , Takashi Sugimura , Miki Tomihari
Cancer Research 48 ( 18) 5275 -5279
36
1988
Loss of DCC Expression and Glioma Progression
Kimberly Rieger-Christ , Paul Kleihues , Eric R. Fearon , Mary Helie
Cancer Research 57 ( 3) 382 -386
65
1997